The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK.

Autor: Vasiliadou I; Guy's and St. Thomas NHS Foundation Trust, London, UK.; King's College London, London, UK., Grose D; Beatson West of Scotland Cancer Centre, Glasgow, UK., Wilson C; Beatson West of Scotland Cancer Centre, Glasgow, UK., Thapa A; Beatson West of Scotland Cancer Centre, Glasgow, UK., Donnelly O; Portsmouth Hospitals NHS Trust, Portsmouth, Hampshire, UK., Lee E; Guy's and St. Thomas NHS Foundation Trust, London, UK.; King's College London, London, UK., Leslie I; Royal Marsden NHS Foundation Trust, London, UK., Karim M; Royal Marsden NHS Foundation Trust, London, UK., Hartley A; Queen Elizabeth Hospital Birmingham, Birmingham, UK., Partridge S; Imperial College Healthcare NHS Trust-Charing Cross Hospital, London, UK., Medlow K; Imperial College Healthcare NHS Trust-Charing Cross Hospital, London, UK., De Boisanger J; Imperial College Healthcare NHS Trust-Charing Cross Hospital, London, UK., Metcalf R; The Christie NHS Foundation Trust, Manchester, UK., Williamson A; The Christie NHS Foundation Trust, Manchester, UK., Haridass A; The Clatterbridge Cancer Centre, Liverpool, UK., Noble D; Edinburgh Cancer Centre, Edinburgh, UK., Mactier K; Edinburgh Cancer Centre, Edinburgh, UK., Walter H; University Hospitals of Leicester, Leicester, UK., Ma N; University Hospitals of Leicester, Leicester, UK., De Winton E; Royal United Hospitals Bath-NHS Foundation trust, Bath, UK., Cohen J; Royal United Hospitals Bath-NHS Foundation trust, Bath, UK., Rayner L; Royal United Hospitals Bath-NHS Foundation trust, Bath, UK., Geropantas K; Norfolk and Norwich University Hospital, Norwich, UK., Jankowska P; Musgrove Park Hospital-Taunton and Somerset NHS Foundation Trust, Taunton, UK., Mason J; Musgrove Park Hospital-Taunton and Somerset NHS Foundation Trust, Taunton, UK., Moleron R; Aberdeen Royal Infirmary-NHS Grampian, Aberdeen, UK., Laws K; Aberdeen Royal Infirmary-NHS Grampian, Aberdeen, UK., Ulahannan D; St. James's University Hospital, Leeds, UK., Nallathambi C; St. James's University Hospital, Leeds, UK., Michaelidou A; Maidstone Hospital-Tunbridge Wells Hospital-NHS Trust, Tunbridge Wells, UK., Nallamilli S; Maidstone Hospital-Tunbridge Wells Hospital-NHS Trust, Tunbridge Wells, UK., Raouf S; St Bartholomew's Hospital, Barts Health NHS Trust, London, UK., Palmer K; King's College London, London, UK.; St Bartholomew's Hospital, Barts Health NHS Trust, London, UK., Bienz M; Mount Vernon Cancer Centre, London, UK., Karet T; Mount Vernon Cancer Centre, London, UK., Khalique S; Mount Vernon Cancer Centre, London, UK., Paterson C; Beatson West of Scotland Cancer Centre, Glasgow, UK., Harrington K; Royal Marsden NHS Foundation Trust, London, UK.; The Institute of Cancer Research, London, UK., Bhide S; Royal Marsden NHS Foundation Trust, London, UK.; The Institute of Cancer Research, London, UK., Kong A; Guy's and St. Thomas NHS Foundation Trust, London, UK.; King's College London, London, UK.

Publikováno v: International journal of cancer [Int J Cancer] 2024 Sep 01; Vol. 155 (5), pp. 883-893. Date of Electronic Publication: 2024 Apr 29.

Come and Hear : What I Saw in My Seven-and-a-Half-Year Journey Through the Talmud

Autor: Adam Kirsch

A literary critic's journey through the Talmud. Spurred by a curiosity about Daf Yomi—a study program launched in the 1920s in which Jews around the world read one page of the Talmud every day for 2,711 days, or about seven and a half years—Adam